Is 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)- Safe in Breastfeeding

Question

I am a breastfeeding mother and i want to know if it is safe to use 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)-? Is 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)- safe for nursing mother and child? Does 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)- extracts into breast milk? Does 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)- has any long term or short term side effects on infants? Can 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)- influence milk supply or can 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)- decrease milk supply in lactating mothers?

Answer by DrLact: About 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)- usage in lactation

No information is available on the clinical use of 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)- during breastfeeding. Because 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)- is 74% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)- therapy and for one month after the last dose.

Alternate Drugs

Vinorelbine(Dangerous)

Ixazomib

Trametinib

Cladribine(Dangerous)

Copanlisib

Fluorouracil(Dangerous)

Dacarbazine(Dangerous)

Midostaurin

Moxetumomab Pasudotox

Atezolizumab

Lapatinib

Alemtuzumab(Low Risk)

Rituximab(Low Risk)

Gemcitabine(Dangerous)

Dactinomycin(Dangerous)

Vincristine(Dangerous)

Dasatinib(Unsafe)

Letrozole(Dangerous)

Dabrafenib

Bevacizumab(Low Risk)

Vismodegib

Cabozantinib

Arsenic Trioxide

Tamoxifen(Dangerous)

Exemestane(Dangerous)

Palbociclib

Thioguanine(Dangerous)

Rucaparib

Cobimetinib

Mitoxantrone(Dangerous)

Vemurafenib

Inotuzumab Ozogamicin

Mercaptopurine(Safe)

Nilotinib(Unsafe)

Erlotinib(Unsafe)

Hydroxyurea(Low Risk)

Etoposide(Dangerous)

Trastuzumab(Unsafe)

Docetaxel(Dangerous)

Doxorubicin(Dangerous)

Pazopanib(Unsafe)

Cyclophosphamide(Dangerous)

Ipilimumab(Unsafe)

Nivolumab(Unsafe)

Imatinib(Unsafe)

Cetuximab(Unsafe)

Cisplatin(Unsafe)

Vinblastine(Dangerous)

Carboplatin(Dangerous)

Bosutinib

Busulfan(Dangerous)

Bleomycin(Dangerous)

Durvalumab

Duvelisib

Azelaic Acid(Safe)

Ado-Trastuzumab Emtansine

Paclitaxel(Dangerous)

Gemcitabine(Dangerous)

Allopurinol(Safe)

Dasatinib(Unsafe)

Orlistat(Low Risk)

Nilotinib(Unsafe)

Erlotinib(Unsafe)

Pazopanib(Unsafe)

Imatinib(Unsafe)

Dasatinib(Unsafe)

Nilotinib(Unsafe)

Erlotinib(Unsafe)

Pazopanib(Unsafe)

Imatinib(Unsafe)

Synonyms of 3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)-

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.